TRACON Pharmaceuticals (TCON) Stock Chart & Stock Price History → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free TCON Stock Alerts $1.85 +0.03 (+1.65%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media TRACON Pharmaceuticals Stock Price Performance5 Day Performance-5.61%1 Month Performance-79.74%3 Month Performance-47.68%6 Month Performance-52.32%Year-To-Date Performance-47.17%1 Year Performance-94.80% Receive TCON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. TCON Stock Chart for Wednesday, April, 24, 2024 TCON Chart by TradingView TRACON Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$1.82$1.85+1.65%$1.96$1.8254,919 shs$4.22 million04/22/2024$1.96$1.82-7.14%$1.94$1.70143,340 shs$4.15 million04/19/2024$2.11$1.96-7.11%$2.14$1.93239,102 shs$4.47 million04/18/2024$2.29$2.11-7.86%$2.34$2.06351,085 shs$4.81 million04/17/2024$1.71$2.29+33.92%$2.89$1.711.97 million shs$5.22 million04/16/2024$1.80$1.71-5.00%$1.93$1.59263,900 shs$3.90 million Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$2.36$1.80-23.73%$2.28$1.72253,730 shs$4.10 million04/12/2024$2.59$2.36-8.88%$2.65$2.25307,162 shs$5.38 million04/11/2024$3.01$2.59-13.95%$3.37$2.55214,005 shs$117.86 million04/10/2024$3.36$3.01-10.47%$3.14$2.70285,094 shs$136.97 million04/09/2024$3.84$3.36-12.45%$4.08$3.03203,320 shs$7.65 million04/08/2024$5.11$3.84-24.79%$5.00$3.70343,615 shs$8.74 million04/05/2024$5.25$5.11-2.67%$5.40$4.6094,143 shs$11.62 million04/04/2024$4.39$5.25+19.50%$5.58$4.52430,170 shs$11.94 million04/03/2024$8.31$4.39-47.18%$8.08$3.72841,811 shs$9.99 million04/02/2024$8.23$8.31+1.05%$8.54$8.0057,583 shs$18.91 million04/01/2024$8.60$8.23-4.30%$8.83$8.2069,365 shs$18.72 million03/29/2024$8.60$8.60$9.20$7.94156,697 shs$19.56 million03/28/2024$8.20$8.60+4.80%$9.20$7.94155,517 shs$19.56 million03/27/2024$8.60$8.20-4.63%$8.60$7.8079,852 shs$18.66 million03/26/2024$9.20$8.60-6.52%$9.20$7.80167,323 shs$19.57 million03/25/2024$9.13$9.20+0.74%$10.00$8.81184,200 shs$20.93 million03/22/2024$8.74$9.13+4.49%$11.00$8.90506,909 shs$20.78 million03/21/2024$7.44$8.74+17.47%$9.00$7.21310,354 shs$19.89 million03/20/2024$7.79$7.44-4.49%$8.00$7.02114,730 shs$16.93 million03/19/2024$7.22$7.79+7.86%$10.20$6.74448,179 shs$17.73 million03/18/2024$7.50$7.22-3.71%$7.60$5.78418,046 shs$16.43 million03/15/2024$8.75$7.50-14.31%$8.60$7.02326,652 shs$11.68 million03/14/2024$12.62$8.75-30.65%$12.40$7.131.03 million shs$13.63 million03/13/2024$7.80$12.62+61.79%$14.75$7.801.32 million shs$19.65 million03/12/2024$5.80$7.80+34.48%$8.02$6.30925,830 shs$12.15 million03/11/2024$4.94$5.80+17.41%$5.88$4.62372,426 shs$9.03 million03/08/2024$4.65$4.94+6.24%$5.20$4.50268,862 shs$7.69 million03/07/2024$3.94$4.65+18.02%$4.80$3.82349,401 shs$7.24 million03/06/2024$3.75$3.94+5.07%$4.00$3.50128,516 shs$6.14 million03/05/2024$3.77$3.75-0.53%$3.80$3.4870,087 shs$5.84 million03/04/2024$3.76$3.77+0.27%$3.80$3.4444,095 shs$5.87 million03/01/2024$3.62$3.76+3.87%$3.95$3.5973,304 shs$5.85 million02/29/2024$3.48$3.62+3.90%$3.78$3.4844,698 shs$5.64 million02/28/2024$3.56$3.48-2.08%$3.69$3.3720,201 shs$5.43 millionElon Musk’s Controversial New Project: “Apollo” (Ad)Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake.02/27/2024$3.66$3.56-2.79%$3.71$3.5326,452 shs$5.54 million02/26/2024$3.32$3.66+10.17%$3.66$3.2629,195 shs$5.70 million02/23/2024$3.60$3.32-7.62%$3.58$3.1766,751 shs$5.17 million02/22/2024$3.62$3.60-0.72%$3.66$3.4432,266 shs$5.60 million02/21/2024$3.72$3.62-2.69%$3.76$3.6017,433 shs$5.64 million02/20/2024$3.74$3.72-0.37%$3.80$3.6020,592 shs$5.80 million02/19/2024$3.74$3.74$3.80$3.6217,915 shs$5.82 million02/16/2024$3.80$3.74-1.79%$3.80$3.6217,547 shs$5.82 million02/15/2024$3.80$3.80+0.11%$3.94$3.6048,056 shs$5.92 million02/14/2024$3.90$3.80-2.56%$4.00$3.6448,371 shs$5.92 million02/13/2024$3.99$3.90-2.26%$4.00$3.8313,085 shs$6.07 million02/12/2024$3.76$3.99+6.17%$4.00$3.7454,135 shs$6.21 million02/09/2024$3.91$3.74-4.50%$3.91$3.6435,391 shs$5.82 million02/08/2024$3.92$3.91-0.05%$4.08$3.8026,492 shs$6.09 million02/07/2024$3.80$3.92+3.05%$3.92$3.7324,541 shs$6.10 million02/06/2024$4.00$3.80-4.90%$3.99$3.6259,966 shs$5.92 million02/05/2024$3.94$4.00+1.42%$4.00$3.7023,233 shs$6.22 million02/02/2024$3.90$3.94+1.03%$3.98$3.7410,724 shs$6.14 million02/01/2024$3.87$3.90+0.83%$3.96$3.7034,132 shs$6.07 million01/31/2024$4.18$3.87-7.38%$4.18$3.7949,117 shs$6.02 million01/30/2024$4.14$4.18+0.87%$4.60$4.0221,327 shs$6.50 million01/29/2024$4.14$4.14$4.40$3.9735,997 shs$6.45 million01/26/2024$4.08$4.14+1.47%$4.40$3.90145,189 shs$6.45 million01/25/2024$3.54$4.08+15.38%$4.20$3.40224,976 shs$6.35 million01/24/2024$3.10$3.54+14.06%$3.60$3.1865,221 shs$5.51 million01/23/2024$3.12$3.10-0.64%$3.18$3.0124,344 shs$4.83 million Related Companies: NanoString Technologies Stock Chart Kiromic BioPharma Stock Chart Avalon GloboCare Stock Chart Eloxx Pharmaceuticals Stock Chart Finch Therapeutics Group Stock Chart Palisade Bio Stock Chart Gamida Cell Stock Chart Fresh Tracks Therapeutics Stock Chart Gamida Cell Stock Chart Windtree Therapeutics Stock Chart Receive TCON Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCON) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.